Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ChromaDex
CDXC
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.70
0.15
4.23%
At Close: -
$3.71
0.0100
0.27%
After Hours: 4:50 PM EDT
15 minutes delayed
Get Report
Comment
ChromaDex (CDXC) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ChromaDex (NASDAQ:CDXC) Stock
ChromaDex Stock (NASDAQ: CDXC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, September 10, 2024
ChromaDex Expands Distribution Of Niagen+ IV ...
Benzinga Newsdesk
Monday, August 19, 2024
ChromaDex Granted U.S. Patent Number 10,000,...
Benzinga Newsdesk
Friday, August 09, 2024
HC Wainwright & Co. Reiterates Buy on ChromaD...
Benzinga Newsdesk
Wednesday, August 07, 2024
ChromaDex Now Expects FY24 Revenue Growth Of ...
Benzinga Newsdesk
ChromaDex Q2 Sales $22.739M Miss $23.437M Est...
Benzinga Newsdesk
Tuesday, July 23, 2024
ChromaDex Launches Niagen+ NAD+ Test Kit Avai...
Benzinga Newsdesk
Tuesday, July 16, 2024
Chromadex Says Board Appointed James Lee As I...
Benzinga Newsdesk
ChromaDex To Ship Pharmaceutical-Grade Intrav...
Benzinga Newsdesk
Monday, July 15, 2024
HC Wainwright & Co. Reiterates Buy on ChromaD...
Benzinga Newsdesk
Monday, July 01, 2024
ChromaDex Joins Russell 2000 Index As Part Of...
Benzinga Newsdesk
Monday, June 24, 2024
Milestone Phase II Clinical Study Demonstrate...
Benzinga Newsdesk
Thursday, June 13, 2024
ChromaDex Unveils Niagen+ With FDA Authorizat...
Benzinga Newsdesk
Wednesday, June 12, 2024
Roth MKM Maintains Buy on ChromaDex, Maintain...
Benzinga Newsdesk
Friday, June 07, 2024
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
ChromaDex shares are trading higher after the...
Benzinga Newsdesk
ChromaDex Announces FDA Orphan Drug And Rare ...
Benzinga Newsdesk
Monday, June 03, 2024
ChromaDex Gets Orphan Designation Status From...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on ChromaD...
Benzinga Newsdesk
Wednesday, May 08, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
ChromaDex Q1 2024 Adj EPS $(0.01) Beats $(0.0...
Benzinga Newsdesk
Tuesday, April 30, 2024
ChromaDex Announces Ingredient Partnership Wi...
Benzinga Newsdesk
Thursday, April 25, 2024
ChromaDex Launches Tru Niagen At The Vitamin ...
Benzinga Newsdesk
Tuesday, April 23, 2024
ChromaDex Announces That Its Flagship Product...
Benzinga Newsdesk
Tuesday, April 09, 2024
Roth MKM Maintains Buy on ChromaDex, Raises P...
Benzinga Newsdesk
Monday, March 18, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Monday, March 11, 2024
HC Wainwright & Co. Maintains Buy on ChromaDe...
Benzinga Newsdesk
Wednesday, March 06, 2024
ChromaDex Expects Trajectory Of 2024 Revenue ...
Benzinga Newsdesk
ChromaDex Q4 EPS $0.00 Beats $(0.03) Estimate...
Benzinga Newsdesk
Earnings Scheduled For March 6, 2024
Benzinga Insights
Tuesday, March 05, 2024
Earnings Preview For ChromaDex
Benzinga Insights
Tuesday, December 12, 2023
Neurohacker Collective And ChromaDex Partner ...
Benzinga Newsdesk
Thursday, November 30, 2023
A Milestone Phase I Randomized, Double-Blind ...
Benzinga Newsdesk
Wednesday, November 15, 2023
ChromaDex New Published Phase II Clinical Stu...
Benzinga Newsdesk
Wednesday, November 08, 2023
ChromaDex: Q3 Earnings Insights
Benzinga Insights
ChromaDex Q3 2023 Gaap EPS $(0.01) Beats $(0....
Benzinga Newsdesk
Earnings Scheduled For November 8, 2023
Benzinga Insights
Tuesday, November 07, 2023
Earnings Outlook For ChromaDex
Benzinga Insights
Wednesday, November 01, 2023
ChromaDex Debuts Clinical Strength Tru Niagen...
Benzinga Newsdesk
Monday, October 02, 2023
ChromaDex Shares Result From A Clinical Study...
Benzinga Newsdesk
Thursday, August 24, 2023
ChromaDex Shares Findings From A Preclinical ...
Benzinga Newsdesk
Thursday, August 10, 2023
HC Wainwright & Co. Reiterates Buy on ChromaD...
Benzinga Newsdesk
Wednesday, August 09, 2023
ChromaDex Sees FY23 Revenue Growth At Least 1...
Benzinga Newsdesk
ChromaDex Q2 EPS $(0.03) Beats $(0.04) Estima...
Benzinga Newsdesk
Earnings Scheduled For August 9, 2023
Benzinga Insights
Tuesday, August 08, 2023
ChromaDex Launches Tru Niagen With iHerb, The World's Number One Online Destination For Health And Wellness
Happy Mohamed
Tuesday, July 18, 2023
ChromaDex Highlights Publication On Abstracts In Association for Research in Vision and Ophthalmology Journal
Bill Haddad
Thursday, June 22, 2023
ChromaDex Corp Files For Mixed Shelf Of Up To...
Benzinga Newsdesk
Monday, June 05, 2023
HC Wainwright & Co. Reiterates Buy on ChromaD...
Benzinga Newsdesk
Wednesday, May 10, 2023
Recap: ChromaDex Q1 Earnings
Benzinga Insights
ChromaDex Q1 EPS $(0.03) Beats $(0.05) Estimate, Sales $22.56M Beat $19.32M Estimate
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
